The University of Liverpool Management School returned to the Financial Times (FT) Global Masters in Finance ranking for 2018.
The ranking lists the top 65 pre-experience programmes globally based on factors such as value for money, career progression, diversity and international mobility.
Only 17 UK schools are placed in this ranking and to participate a school must be accredited and have met specific criteria.
Information provided by the business schools is used to calculate the rankings, along with data from alumni in areas including ‘careers service’ and ‘career progress’.
The success follows on from the Management School’s appearance in The Economist’s WhichMBA? Masters in Management rankings in 2017.
Management School Dean, Professor Julia Balogun said: “We are delighted that our MSc Finance has been ranked in the FT master in Finance (Pre-experience) rankings 2018.
“This provides an indication of the standing of our programme for our alumni, and current and future students.“
Management School Associate Dean, Postgraduate, Professor Lisa Anderson said: “This is great news for everyone involved in the MSc Finance programme at the Management School.
“We have a great team who challenge and support our students to set their aspirations high and to achieve the highest standards.”
You must be logged in to post a comment.
All recent news
Maria Balshaw: “absolutely unbelievable” to be returning as Honorary Graduate
GALLERY: Graduation 2018
Compound identified that protects against neurodegeneration
New collaborative agreements with XJTU and Sichuan University
University Professor helps Academy of Medical Sciences win national award
Our Chancellor Colm Tóibín presents Professor Dame Jane Dacre with her Honorary Degree of Doctor of Medicine at this week's final #LivuniGrad ceremony. Congratulations @DacreJane!
Director @Tate Maria Balshaw tells us her Liverpool student self would consider it “absolutely unbelievable” to be returning 27 years later as an Honorary Graduate https://t.co/9QZKjR9fWF
Our multidisciplinary team develops novel neuroprotective molecule with 100 times the potency of the antiepileptic drug ethosuximide, shown to protect against conditions like #Parkinsons #Alzheimers and #Huntingtons https://t.co/JuYQoS4lRk @wellcometrust